|
Mar 25
|
Bolt Biotherapeutics to Present Data from Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025
|
|
Mar 24
|
Bolt Biotherapeutics Inc.: Q4 Earnings Snapshot
|
|
Mar 24
|
Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
|